(CLOSED) HRSA-20-013 Addiction Medicine Fellowship Program

Sponsor Name: 
Health Resources and Services Administration
Description of the Award: 

Program Purpose

The purpose of the AMF Program is to expand the number of fellows at accredited AMF and Addiction Psychiatry Fellowship (APF) programs trained as addiction medicine specialists who work in underserved, community-based settings that integrate primary care with mental health disorder and substance use disorder (SUD) prevention and treatment services. The AMF Program encompasses both psychiatry and an addiction subspecialty for primary care doctors.

Program Goals

The AMF Program is designed to foster robust community-based clinical training of addiction medicine or addiction psychiatry physicians in underserved, community-based settings who see patients at various access points of care and provide addiction prevention, treatment, and recovery services across healthcare sectors.

Program Objectives

  • Increase the number of board certified addiction medicine or addiction psychiatry sub-specialists produced per program annually by providing stipends for new addiction medicine or addiction psychiatry fellowship slots and additional program support to sponsoring institutions.
  • Collaborate and establish formal relationships with underserved, community-based settings (such as HRSA-supported health centers,2 integrated behavioral health community health centers, Medication Assisted Treatment (MAT) facilities, and affiliated evidence-based substance use treatment centers) to provide training of AMF Program fellows at these sites.
  • Develop or enhance training for faculty from collaborating programs to create an infrastructure of skills and expertise that supports training fellows to provide opioid use disorder (OUD) and other SUD prevention, treatment and recovery services on integrated, interprofessional teams.

HHS and HRSA Priorities

This program will build upon HRSA’s existing OUD and other SUD investments and support the U.S. Department of Health and Human Services (HHS) initiative to combat the opioid crisis. It is expected that you address the first two priorities below and, if applicable, the third:

  • Combatting the opioid crisis/Mental Health disorders
  • Transforming the workforce –targeting the need
  • Expanding telehealth services

HRSA expects approximately $26,700,000 to be available annually to fund 33 award recipients. You may apply for a ceiling amount of up to $800,000 total cost (includes both direct and indirect, facilities and administrative costs) per year. The actual amount available will not be determined until enactment of the final FY 2020 federal appropriation. This Program notice is subject to the appropriation of funds, and is a contingency action taken to ensure that, should funds become available for this purpose, HRSA can process applications and award funds in a timely manner.

Limit (Number of applicants permitted per institution): 
Sponsor Final Deadline: 
Feb 25, 2020
OVPR Application or NOI Instructions: 

Internal Nomination Process:

If you are planning to apply please provide your contact information using the Submit Application button on the Infoready website. If interest exceeds the sponsor's institutional limit, the Office of the Senior Vice President for Research will hold an internal Limited Submissions competition.

Questions concerning the limited submissions process may be submitted to limitedsubs@psu.edu.

To be considered as a Penn State institutional nominee, please submit a notice of intent by the date provided directly below.
Penn State OVPR NOI Deadline: 
Tuesday, February 18, 2020 - 4:00pm
This limited submission is in downselect: 
Penn State may only submit a specific number of proposals to this funding opportunity. The number of NOIs received require that an internal competition take place, thus, a downselect process has commenced. No Penn State researchers may apply to this opportunity outside of this downselect process. To apply for this limited submission, please use this link:
OVPR Downselect Deadline: 
Tuesday, February 18, 2020 - 4:00pm
Sheryl Ryan (CoM)